Literature DB >> 26003083

Effect of enhanced expression of connexin 43 on sunitinib-induced cytotoxicity in mesothelioma cells.

Miaki Uzu1, Hiromi Sato2, Ryota Yamada1, Tatsuro Kashiba1, Yukihiro Shibata1, Katsunori Yamaura1, Koichi Ueno3.   

Abstract

Connexin (Cx) makes up a type of intercellular channel called gap junction (GJ). GJ plays a regulatory role in cellular physiology. The Cx expression level is often decreased in cancer cells compared to that in healthy ones, and the restoration of its expression has been shown to exert antiproliferative effects. This work aims to evaluate the effect of the restoration of connexin 43 (Cx43) (the most ubiquitous Cx subtype) expression on sunitinib (SU)-induced cytotoxicity in malignant mesothelioma (MM) cells. Increased Cx43 expression in an MM cell line (H28) improved the ability of SU to inhibit receptor tyrosine kinase (RTK) signaling. Moreover, higher Cx43 expression promoted SU-induced apoptosis. The cell viability test revealed that Cx43 enhanced the cytotoxic effect of SU in a GJ-independent manner. The effect of Cx43 on a proapoptotic factor, Bax, was then investigated. The interaction between Cx43 and Bax was confirmed by immunoprecipitation. Furthermore, higher Cx43 expression increased the production of a cleaved (active) form of Bax during SU-induced apoptosis with no alteration in total Bax expression. These findings indicate that Cx43 most likely increases sensitivity to SU in H28 through direct interaction with Bax. In conclusion, we found that Cx43 overcame the chemoresistance of MM cells.
Copyright © 2015 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Connexin; Drug resistance; Mesothelioma; Sunitinib

Mesh:

Substances:

Year:  2015        PMID: 26003083     DOI: 10.1016/j.jphs.2015.04.002

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  10 in total

1.  [Effect of gap junction modulation on antitumor effects of adriamycin in estrogen receptor-positive breast cancer cells].

Authors:  Guojun Jiang; Yaming Liu; Wanchen Zhao; Daoxin Wang; Shuying Dong; Xuhui Tong
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

2.  Connexin hemichannels influence genetically determined inflammatory and hyperproliferative skin diseases.

Authors:  Noah A Levit; Thomas W White
Journal:  Pharmacol Res       Date:  2015-07-23       Impact factor: 7.658

3.  Connexin 43 expression is associated with poor survival in patients with esophageal squamous cell carcinoma.

Authors:  Tatsuya Tanaka; Masahiro Kimura; Hideyuki Ishiguro; Kouji Mizoguchi; Hiromitsu Takeyama
Journal:  Mol Clin Oncol       Date:  2016-03-22

4.  The Multifunction Of miR-218-5p-Cx43 Axis In Breast Cancer.

Authors:  Chen Xia; Hong Jiang; Fugui Ye; Zhigang Zhuang
Journal:  Onco Targets Ther       Date:  2019-10-08       Impact factor: 4.345

Review 5.  Connexin and pannexin channels in cancer.

Authors:  Jean X Jiang; Silvia Penuela
Journal:  BMC Cell Biol       Date:  2016-05-24       Impact factor: 4.241

6.  Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.

Authors:  Ewa Maj; Beata Filip-Psurska; Magdalena Milczarek; Mateusz Psurski; Andrzej Kutner; Joanna Wietrzyk
Journal:  Int J Oncol       Date:  2017-12-15       Impact factor: 5.650

Review 7.  Conflicting Roles of Connexin43 in Tumor Invasion and Growth in the Central Nervous System.

Authors:  Miaki Uzu; Wun Chey Sin; Ayaka Shimizu; Hiromi Sato
Journal:  Int J Mol Sci       Date:  2018-04-11       Impact factor: 5.923

Review 8.  Connexins and Pannexins: Important Players in Tumorigenesis, Metastasis and Potential Therapeutics.

Authors:  Sheila V Graham; Jean X Jiang; Marc Mesnil
Journal:  Int J Mol Sci       Date:  2018-06-01       Impact factor: 5.923

9.  Prognostic and Clinic Pathological Value of Cx43 Expression in Glioma: A Meta-Analysis.

Authors:  Chao Zhang; Cheng-Fen Liu; An-Bin Chen; Zhong Yao; Wei-Guo Li; Shu-Jun Xu; Xiang-Yu Ma
Journal:  Front Oncol       Date:  2019-11-12       Impact factor: 6.244

10.  Citrus Flavone Tangeretin Inhibits CRPC Cell Proliferation by Regulating Cx26, AKT, and AR Signaling.

Authors:  Ningfang Zhang; Wenqi Wu; Yapeng Huang; Lingyue An; Zhichan He; Zhenglin Chang; Zhaohui He; Yongchang Lai
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-24       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.